Impact of Virtual Reality on the Quality of Life of Oncology Patients
Central Hospital Saint Quentin
150 participants
Nov 1, 2023
INTERVENTIONAL
Conditions
Summary
Anxiety, nausea and vomiting are common side effects in paediatric patients receiving chemotherapy. chemotherapy. New evidence supports the efficacy of immersive virtual reality in improving symptoms of anxiety and distress, including nausea and vomiting, in this vulnerable group. This research will evaluate the efficacy of virtual reality in managing anxiety, nausea and vomiting in cancer patients receiving their first line of chemotherapy and will also measure the quality of life of these patients and evaluate patient and nursing staff satisfaction
Eligibility
Inclusion Criteria6
- Chemotherapy-naive patient
- Patient with first-line indication for intravenous cyclic chemotherapy
- Affiliated to a social security system
- Having received full information on the organization of the research and having given free, informed and written consent signed by the participant and the investigator
- Patient understands French or English
- Expected duration of chemotherapy session for the first 3 cycles greater than 30 minutes
Exclusion Criteria12
- Patient with communication disorders preventing informed consent
- Patient under legal protection (guardianship, curatorship, safeguard of justice)
- Patients suffering from epilepsy
- Severe visual or hearing impairment preventing use of headphones
- Psychiatric pathologies such as delusional disorders, hallucinations or schizophrenia.
- Patients with infections or facial wounds
- Patients with severe claustrophobia
- Patients with pacemakers
- Patients with known cognitive or learning problems,
- Patients with brain tumors or metastases,
- Patients suffering from motion sickness
- Expected duration of chemotherapy session for the first 3 cycles of 30 minutes or less.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Improvment of quality of life is measured by the QLQ-C30 quality of life questionnaire
Patient satisfaction is measured using a five-point scale ranging from 1 = strongly disagree to 5 = strongly agree. Higher scores indicate higher levels of satisfaction.
Anxiety and pain is measured by Visual Analogue Scale (VAS). This measurement is complemented by physiological responses to anxiety, measured by heart rate and mean arterial blood pressure (HR and BP)
Depressive State is measured by HAD score
Fatigue levels is measured by Visual Analogue Scale (VAS).
acute nausea and vomiting is measured by MASCC Antiemesis Tool (MAT)
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06485869